Easton Capital Investment Group is a private investment firm that targets early stage venture capital to later stage growth capital investments. Easton will consider opportunities across a range of industries, but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. Easton looks to commit $0.50 to $7.5 million per transaction. Easton Capital was formed in 2000 and has offices in New York City and Coral Gables, Florida.
Join Mergr to view the latest updates and news from New York-based Easton Capital Investment Group.
Easton Capital Investment Group’s most common sectors for investment are life science (48%) and healthcare services (12%). The Firm’s most common investment types include venture (84%) and buyout (lbo, mbo, mbi) (12%). In total, Easton Capital Investment Group has invested in 10 US states. Its largest (disclosed) acquisition occurred in 2010 when it acquired bluebird bio for $35M.
The Firm’s most common exit type is trade sale (53%). Easton Capital Investment Group’s largest (disclosed) exit occurred in 2007 when it sold Conor Medsystems for $1.4B.
Join Mergr to view Easton Capital Investment Group’s full profile and discover more small private equity firms just like it.
No obligation. Cancel anytime.